147 views | 1 decade ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses why he chooses Illumina technology for NIPT, PGS, and PGD. Learn more about how next-generation sequencing (NGS)...
366 views | 1 decade ago
Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests...
412 views | 1 decade ago
Some people struggle more to lose weight than others. The Fat mass and obesity-associated (FTO) gene is the first gene identified by genome-wide association studies as a strong candidate for obesity-related...
1927 views | 1 decade ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing for preimplantation genetic...
247 views | 1 decade ago
Highlights from the Illumina User Meeting at AGBT 2015.
1519 views | 1 decade ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses the high-throughput, high-resolution advantages of next-generation sequencing http://technology.illumina.com/technology/next-generation-sequencing.html...
116 views | 1 decade ago
Francesco Fiorentino, Director of Genoma Molecular Genetics Laboratory, Rome, Italy, discusses why he feels Preimplantation Genetic Screening (PGS) should be applied in every IVF treatment. His findings...
848 views | 1 decade ago
Dr. Kaylen Silverberg discusses the latest advancements in preimplantation screening (PGS) and summarizes several key IVF studies. He highlights the advantages of incorporating PGS into today s fertility...